-+ 0.00%
-+ 0.00%
-+ 0.00%

J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner

PUBT·08/18/2026 13:03:13
Listen to the news
J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner
  • JPMorgan appointed Bruce N. Rogers as venture partner at J.P. Morgan Life Sciences Private Capital.
  • Rogers is president and CEO of a precision immunology portfolio company backed by the unit.
  • He previously led Morphic Therapeutic, joining in 2016 as chief scientific officer, before its USD 3.2 billion sale to Eli Lilly in 2024.
  • Rogers later served at Eli Lilly as senior vice president and CEO of Morphic, overseeing integration of the business.
  • Earlier roles included head of neuro-opportunities at Pfizer, with 16 years in medicinal chemistry at Pfizer and Pharmacia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JPMorgan Chase & Co. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY27655) on August 18, 2026, and is solely responsible for the information contained therein.